IPMC 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
3rd Edition of International Precision Medicine Conference
March 13-15, 2025
International
Precision Medicine Conference
Event Book
Event program
Scientific Program
About
Magnus Group extends the gratitude and sincere thanks to the participants of International Precision Medicine Conference: Virtual Event held during April 19 -21, 2021.
The conference was characterized by the participation of brilliant and accomplished scholars, medical professionals, delegates and talented students from more than 20 nations.IPMC 2021 has taken privilege of Honoring the Keynote Speakers and Plenary Speakers whose talks made this meeting more informative and driven the event into the path of success.
We would like to give special thanks all the Delegates and Poster Presenters who attended the webinar and supported the conference by facilitating active discussion forums.Hopefully, you have enjoyed being a part of this Precision Medicine Congress and also we believe that you can make a significant contribution and continued support to our upcoming series of conferences in the future.
The Meeting was not meant to be a single event, but a starting point for a series of events that helps to promote healthcare and improvise patient care around the Globe.
Scientific Committee Members
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Huiqin Yang
ICON Clinical Research Ltd, United Kingdom
Alexander G Haslberger
University of Vienna, Austria
Guangju Zhai
Memorial University of Newfoundland, Canada
Gad Rennert
Technion-Israel Institute of Technology, IsraelSpeakers
Bruce K Kowiatek
Blue Ridge Community and Technical College, United States
Jawad Alzeer
University of Zurich, Switzerland
Jiandi Zhang
Quanticision Diagnostics Inc, United States
Jeffrey K Mills
Medler Ferro Woodhouse & Mills, United States
Pamela D Price
The Balm In Gilead, United States
Laura Kelly
Opal Health, United States
Benjamin Longo Mbenza
Lomo University of Research, Congo, the Democratic Republic of the
Arezou A Ghazani
Harvard Medical School, United States
Ingrid Vasiliu Feltes
MEDNAX, United States
Pisamai Natun
Mahidol University Amnatcharoen Campus, Thailand
Xu Chen
The College of St. Scholastica, United States
Sean Hall
Medlab Clinical LTD, Australia
Laurent Metzinger
Universite de Picardie Jules Verne, France
Gad Rennert
Technion-Israel Institute of Technology, Israel
Guangju Zhai
Memorial University of Newfoundland, Canada
Nicolo Mauro
University of Palermo, Italy
Andres D Klein
Clínica Alemana Universidad del Desarrollo, Chile
Antonina Mitrofanova
Rutgers Cancer Institute of New Jersey, United States
Milena Cavic
Institute for Oncology and Radiology of Serbia, SerbiaGallery
Reviews
Title : Personalized and precision medicine as a unique healthcare model through the view of biodesign and translational armamentarium of the newest generation
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Importance of personalized precision nutrition and functional foods in healthy aging
Alexander G Haslberger, University of Vienna, Austria
Title : The Role of Metabolomics in Precision Medicine of Osteoarthritis: Where Are We Now?
Guangju Zhai, Memorial University of Newfoundland, Canada
Title : Evaluation of clinical effectiveness of using enzyme-linked immunosorbent assay (ELISA) tests for measuring drug levels and/or their anti-drug antibodies for the purpose of monitoring treatment response and guiding decisions about the use of tumour necrosi
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Implementing a comprehensive precision medicine paradigm into primary care clinics
Gad Rennert, Technion-Israel Institute of Technology, Israel
Title : A machine learning approach to identify a circulating microRNA signature for Alzheimer disease
Xuemei Zhao, Merck & Co., United States